HALO · Company research
Halozyme Therapeutics, Inc. (HALO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 110.79 | $13,782,965,880 | 13619827880.00 | 59.4157894736842105 | — | 1.3863684210526321 | 28.6548742928779478 | 96.0197702430630543 | 58.2252548602134197 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.